| # | Drug | Count |
|---|---|---|
| 0 | ALBUTEROL SULFATE | 72 |
| 1 | FAMOTIDINE | 68 |
| 2 | LORATADINE | 68 |
| 3 | ESOMEPRAZOLE MAGNESIUM | 65 |
| 4 | INSULIN GLARGINE | 65 |
| 5 | LORATADINE ORAL | 65 |
| 6 | MONTELUKAST | 65 |
| 7 | ANASTROZOLE | 64 |
| 8 | APIXABAN | 64 |
| 9 | ESOMEPRAZOLE | 63 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PROMETHAZINE HYDROCHLORIDE | 56 | 0.0030 |
| 1 | INSULIN GLARGINE-YFGN | 62 | 0.0028 |
| 2 | ELRANATAMAB-BCMM | 3 | 0.0026 |
| 3 | VANZACAFTOR, TEZACAFTOR, AND DEUTIVACAFTOR | 2 | 0.0025 |
| 4 | ANASTROZOLE TABLETS | 52 | 0.0024 |
| 5 | CARBAMIDE PEROXIDE | 1 | 0.0023 |
| 6 | ESOMEPRAZOLE MAGNESIUM DIHYDRATE | 28 | 0.0019 |
| 7 | ANASTROZOLE | 64 | 0.0017 |
| 8 | NIRSEVIMAB | 3 | 0.0017 |
| 9 | MERCAPTOPURINE | 29 | 0.0017 |
| # | Drug class | Count |
|---|---|---|
| 0 | Proton Pump Inhibitor [EPC] | 75 |
| 1 | Histamine-2 Receptor Antagonist [EPC] | 69 |
| 2 | Corticosteroid [EPC] | 68 |
| 3 | Factor Xa Inhibitor [EPC] | 66 |
| 4 | Insulin Analog [EPC] | 66 |
| 5 | Aromatase Inhibitor [EPC] | 64 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 57 |
| 7 | Leukotriene Receptor Antagonist [EPC] | 44 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 42 |
| 9 | Alkylating Drug [EPC] | 32 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] | 3 | 0.0017 |
| 1 | Leukotriene Receptor Antagonist [EPC] | 44 | 0.0015 |
| 2 | Asparagine-specific Enzyme [EPC] | 17 | 0.0013 |
| 3 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 4 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 3 | 0.0009 |
| 5 | CD38-directed Cytolytic Antibody [EPC] | 5 | 0.0009 |
| 6 | Aromatase Inhibitor [EPC] | 64 | 0.0006 |
| 7 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 8 | Histamine-2 Receptor Antagonist [EPC] | 69 | 0.0005 |
| 9 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 2 | 0.0005 |